All In Biotech

Drug Trial Radar · NCT06129539

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)

LIBELULA™: An Open-label, Single-arm, Multi-center, Phase 3 Study on the Efficacy, Safety, and Pharmacokinetics of Debio 4326, a Triptorelin 12-month Formulation, in Pediatric Participants With Central Precocious Puberty

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

56

Actual

Start

Jul 31, 2024

Primary completion

Oct 9, 2026

Study completion Feb 2028

Sponsor

Lead sponsor
Debiopharm International SAIndustry
Sponsor type
Industry
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 8 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the efficacy of Debio 4326 in suppressing serum luteinizing hormone (LH) to prepubertal levels 52 weeks after the first Debio 4326 injection in pediatric participants with central precocious puberty (CPP).

Conditions

  • Central Precocious Puberty

Interventions

  • Debio 4326Drug

    Administered as an intramuscular (IM) injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Percentage of Participants With Suppression of Gonadotropin-Releasing Hormone Agonist Stimulated Serum Luteinizing Hormone (LH) to Less Than or Equal to (≤)5 International Units per Liter (IU/L)Time frame: Week 52 in Part A

Locations

17 sites in 5 countries. Site status is shown where the registry gives one.

  • Rady Children's Hospital - San Diego

    San Diego, California

  • University of California San Francisco-Benioff Children's Hospital

    San Francisco, California

  • Prisma Health Pediatric Endocrinology

    Columbia, South Carolina

  • Instituto de Investigaciones Metabolicas (IDIM)

    Buenos Aires, Argentina

  • Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada

    Buenos Aires, Argentina

  • Centro de Investigaciones Medicas Mar del Plata

    Mar del Plata, Argentina

  • Clinica Mayo de Urgencias Medicas Cruz Blanca S.R.L

    San Miguel de Tucumán, Argentina

  • Hospital Da Criança de Brasília Jose Alencar

    Brasília, Brazil

  • Hospital Universitario Walter Cantidio

    Fortaleza, Brazil

  • Clínica de Endocrinologia e Metabologia Ltda

    Lago Sul, Brazil

  • Nucleo de Pesquisa Clínica do Rio Grande do Sul-NPCRS

    Porto Alegre, Brazil

  • CPQuali Pesquisa Clinica

    São Paulo, Brazil

  • Irmandade Santa Casa de São Paulo

    São Paulo, Brazil

  • Integral Pesquisa e Ensino

    Votuporanga, Brazil

  • ENDOMET

    Antofagasta, Chile

  • Hospital Clinico San Borja Arriaran (HCSBA)

    Santiago, Chile

  • Christus Latam Hub Center of Excellence and Innovation S C

    Monterrey, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.